RIL Plans Foray Into Genomic Diagnostics

The energy-to-retail conglomerate is leveraging Strand Life Sciences for its entry into the emerging areas of specialised healthcare diagnostics and genomic sciences. Reliance had acquired the Bengaluru-based company for ₹393 crore in 2021.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/DRCVhtA
via